LEADER 02810nam  2200589 a 450 
001 9910954385003321
005 20200520144314.0
010   $a9781608051427
010   $a1608051420
035   $a(CKB)2670000000099380
035   $a(EBL)864309
035   $a(OCoLC)779141452
035   $a(SSID)ssj0000672883
035   $a(PQKBManifestationID)11417123
035   $a(PQKBTitleCode)TC0000672883
035   $a(PQKBWorkID)10636419
035   $a(PQKB)11579601
035   $a(MiAaPQ)EBC864309
035   $a(Au-PeEL)EBL864309
035   $a(CaPaEBR)ebr10492620
035   $a(DE-B1597)731776
035   $a(DE-B1597)9781608051427
035   $a(EXLCZ)992670000000099380
100   $a20110922d2011      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aIn silico lead discovery /$fby Maria A. Miteva
205   $a1st ed.
210   $a[Saif Zone, Sharjah, United Arab Emirates] $cBentham Science Publishers Ltd.$d[2011]
215   $a1 online resource (201 p.)
300   $aDescription based upon print version of record.
311 08$a9781608053131 
311 08$a160805313X 
320   $aIncludes bibliographical references and index.
327   $a01 Title.pdf; 02 Cover Page; 03 eBooks End User License Agreement-Website; 04 Content; 05 Foreword_Grigirov; 06 Preface_Miteva; 07 Contributors_Proposal_forEbook-MariaMiteva; 08 Chapter 1 Lagorce_et al_revised 2; 09 Chapter 2 Sperandio_et al_revised 2; 10 Chapter 3 Guyon_Tuffery_corrected 2; 11 Chapter 4 Todorov_corrected 2; 12 Chapter 5 Alexov_revised 2; 13 Chapter 6 Miteva_revised 2; 14 Chapter 7 Roche-revised 2; 15 Chapter 8 Pajeva_Wiese_revised 2; 16 Chapter 9 Moro_revised 2; 17 Chapter 10 Lee; 18 Index
330   $aComputer-aided drug design and in silico screening have contributed to the discovery of several compounds that have either reached the market or entered clinical trials. In silico Lead Discovery is a compilation of the efforts of several experts on bioinformatics and drug design in developing the latest advances of in silico approaches for lead discovery. It contains an overview of structure-based, ligand-based methods and current fragment-based methods as well as examples for successful applications of such methods in discovering new hit/lead molecules for important therapeutic targets. Treat
606   $aDrug development
606   $aDrug development$xComputer simulation
615  0$aDrug development.
615  0$aDrug development$xComputer simulation.
676   $a615/.19
700   $aMiteva$b Maria A$01800595
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910954385003321
996   $aIn silico lead discovery$94345449
997   $aUNINA